With the completion of the acquisition, ZOLL Medical, a US-based manufacturer of medical devices, has become a wholly owned consolidated subsidiary of Asahi.
ZOLL will continue to be managed by its current management team, Asahi Kasei said.
ZOLL’s stock will cease to be traded on the NASDAQ market, and ZOLL will not have reporting obligations under the Securities Exchange Act of 1934.
ZOLL provides a set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.